Astrana Health (ASTH) Receivables - Net (2011 - 2026)

Astrana Health has disclosed Receivables - Net across 16 years of filings, most recently posting $467.4 million for Q1 2026.

• Receivables - Net for Q1 2026 came in at $467.4 million, up 93.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $467.4 million (up 93.88% YoY), and the FY2025 annual result was $374.5 million, up 35.68% from the prior year.
• Receivables - Net came in at $467.4 million for Q1 2026 at Astrana Health, up from $374.5 million in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $467.4 million in Q1 2026 to a low of $1.0 million in Q1 2022.
• The 5-year median for Receivables - Net is $76.0 million (2024), against an average of $161.3 million.
• Across the five-year window, Receivables - Net plunged 93.88% in 2022 and surged 7447.67% in 2023, its largest moves.
• Astrana Health's Receivables - Net stood at $62.4 million in 2022, then dropped by 5.95% to $58.7 million in 2023, then surged by 370.11% to $276.0 million in 2024, then surged by 35.68% to $374.5 million in 2025, then gained by 24.82% to $467.4 million in 2026.
• The last three Receivables - Net figures came in at $467.4 million (Q1 2026), $374.5 million (Q4 2025), and $381.2 million (Q3 2025), per Business Quant data.